Nanette Cocero - 07 Jun 2023 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Director
Signature
/s/ Paul Bavier, Attorney-in-fact
Issuer symbol
HLVX
Transactions as of
07 Jun 2023
Net transactions value
$0
Form type
4
Filing time
09 Jun 2023, 18:41:57 UTC
Previous filing
10 May 2023
Next filing
30 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLVX Stock Option Award $0 +11,000 $0.000000 11,000 07 Jun 2023 Common Stock 11,000 $17.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest and become exercisable in substantially equal monthly installments over three years, commencing on May 8, 2023, subject to the reporting person's continued service on the board of directors of the Issuer through each such vesting date.